IBC Policies

The Institution Biosafety Committee (IBC) is responsible for the review of University research and teaching activities involving recombinant and synthetic nucleic acid molecules, infectious agents, biologically-derived toxins, or other potentially hazardous biological agents as described in the University of Minnesota Board of Regents Policy.

The IBC’s policies are periodically evaluated and revised as influenced by regulatory agencies and administrative changes.

All approved policy revisions will be posted on this site as they are implemented, along with the revision date for reference. The most current version of all Institutional Biosafety Committee policies are listed here. 

General Administration

Number	Title
	University of Minnesota Board of Regents Policy
100	Role, Authority, Regulatory Charge
101	Role of the Institutional Official
102	Policy and Procedure Maintenance
103a	Training and Education of IBC Members
103b	Training and Education of IBC Support Staff
104	Management of HRPP/IBC Personnel
105	Signature Authority
106	Voicing Concerns

Organization & Roles of IBC

Number	Title
200	Management of IBC Membership
200a	Role and Composition of Executive Committee
201	Membership and Roster Management
202	Management of IBC Members &Consultant Conflict of Interest
203a	Committee Chairpersons Responsibilities
203b	Member Responsibilities
203c	Consultants
204	Role of the Biological Safety Officer (BSO)

Functions & Operations

Number	Title
301	Application Requirements
302	Administrative Pre-Review
303	Distribution of Meeting Materials
304	Convening an IBC Meeting
305	Minutes of Meetings
306	Records Management
307	Communication with Researchers & Research Community
308	Access to Meetings
309	IBC Interaction with IRB in Research that Includes Human Subjects
310	Process for Working with IACUC
311	UMN Components That Work Directly with the IBC

Review of Research/Activities

Number	Title
400	Initial Review of Research
401	Continuing Review
402	Modifications of Previously Approved Activities
403	Minnesota Laws that Affect IBC
404	Actions Taken by the Committee
405	Non-Compliance with IBC Policies & Procedures
406	Inactivation, Expired Protocol, and Completed Studies
407	Reporting Requirements
407a	Reporting Requirements for SAE in HGT Research
408	Suspension and Termination
408a	Appeals of Suspensions and Terminations
409	Reporting Research Related Incidents
410	Review of Research that Requires BSL-3 Containment
411	Infectious (Not to Humans) Pathogens

Investigator Responsibilities

Number	Title
700	Principal Investigator Responsibilities
701	Researcher Training and Education
702	Researcher Signature Requirements
703	Disagreement with Committee Decisions
704	Certification of Biological Safety Cabinets
705	Determination of Potential Conflict of Interest for Researchers